CareLit · DOI-Nachweis · Senologie - Zeitschrift für Mammadiagnostik und -therapie
LIBERATE trial: A safety study of tibolone in breast cancer surgery patients
DOI 10.1055/s-2006-953663
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMW Beckmann, J Foidard, N Bundred, P Kenemans, E Kubista, B von Schoultz, P Sismondi, R Vassilopoulou-Sellin, C Yip, R Kimmig
ZeitschriftSenologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe10/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background/Objectives: Hormone therapy is contraindicated in women with a history of breast cancer. Tibolone does not stimulate breast tissue and is an agent to treat vasomotor symptoms. LIBERATE is a randomized, double-blind 5-year trial to evaluate that tibolone 2.5mg/day is non-inferior to placebo. Methods: Patients had treated invasive breast carcinoma (T1–3, N0–2, M0). The primary end-point is breast cancer rec…
Zitieren
Zitierempfehlung
MW Beckmann, J Foidard, N Bundred, P Kenemans, E Kubista, B von Schoultz, P Sismondi, R Vassilopoulou-Sellin, C Yip, R Kimmig (2006) LIBERATE trial: A safety study of tibolone in breast cancer surgery patients. Senologie - Zeitschrift für Mammadiagnostik und -therapie (10). https://doi.org/10.1055/s-2006-953663
Mit CareLit weiterarbeiten